Overcoming Cultural and Technological Hurdles for AI Integration in Life Sciences - with Daniel Ferrante of Deloitte

Today’s guest is Daniel Ferrante, AI Leader in R&D and Data Strategy at Deloitte. Together with Emerj CEO and Head of Research Daniel Faggella, they delve into the complex challenges in AI adoption that major pharmaceutical firms encounter with cultural shifts, technological complexities, and the difficulties in monetizing data and aligning teams efficiently. Additionally, the pair explores the future landscape of phenotypical drug discovery, drawing insights from the context of COVID-19. Their focus underscores the critical importance of collecting and …

adoption ai adoption ai integration ceo challenges complexities daniel data data strategy deloitte head integration leader life life sciences major pharmaceutical research strategy together